Related Experiment Videos
Necrobiosis lipoidica and silicotic granulomas on Muller's phlebectomy scars
1Dermatologue FMH, Renens.
Abstract:
We report an unusual case of concomitant necrobiosis lipoidica and silicotic granulomas in scars of phlebectomies on the legs, suggestive of a Koebner phenomenon.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Emergency medicine: updates 2012].
Revue medicale suisse·2013
Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions.
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2010
Veno-active drugs in the management of chronic venous disease. An international consensus statement: current medical position, prospective views and final resolution.
Clinical hemorheology and microcirculation·2005
[Organization model for postoperative pain management in a basic-care hospital].
Der Anaesthesist·2004
The efficacy and safety of a coumarin-/troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency: a double blind placebo-controlled randomised study.
VASA. Zeitschrift fur Gefasskrankheiten·2002
Erratum.
Dermatology (Basel, Switzerland)·2026
Genotypic and Phenotypic Profiles of Babies with Collodion Membrane in a Tertiary Care Center in Riyadh, Saudi Arabia.
Dermatology (Basel, Switzerland)·2026
Real-World Treatment Response to Adalimumab and Secukinumab in Chinese Adults with Hidradenitis Suppurativa: A Retrospective Cohort Study.
Dermatology (Basel, Switzerland)·2026
The Skin and Gut Microbiome in Hidradenitis Suppurativa.
Dermatology (Basel, Switzerland)·2026
Comparison of sunscreen products for babies and children with those for adults.
Dermatology (Basel, Switzerland)·2026
Mixed-phenotype acute leukemia: Flow cytometric analysis in a tertiary care center of Bangladesh.
Leukemia research reports·2026
Antimicrobial susceptibility patterns in Jalisco, Mexico: a snapshot of regional resistance (2021-2023).
Frontiers in cellular and infection microbiology·2026